MyFinsight
Home
Blog
About
Contact
Download
Download image
Belbuca
$52,649K
(1.92%↑ Y/Y)
Xtampza ER
$50,769K
Jornay Pm
$38,893K
(36.28%↑ Y/Y)
Nucynta IR
$26,078K
Nucynta ER
$18,233K
Symproic
$4,194K
(48.99%↑ Y/Y)
Nucynta ERAG
$1,446K
Nucynta IRAG
$1,258K
Product revenues, net
$193,520K
(8.87%↑ Y/Y)
Gross profit
$117,246K
(20.47%↑ Y/Y)
Total cost of product
revenues
$76,274K
(-5.17%↓ Y/Y)
Income from operations
$30,896K
(42.46%↑ Y/Y)
Interest income
$3,706K
(66.56%↑ Y/Y)
Total operating
expenses
$86,350K
(14.16%↑ Y/Y)
Intangible asset
amortization
$55,473K
(0.00%↑ Y/Y)
Cost of product
revenues (excluding...
$20,801K
(-16.66%↓ Y/Y)
Income before income
taxes
$18,740K
(500.26%↑ Y/Y)
Interest expense
$15,862K
(-23.70%↓ Y/Y)
Selling, general and
administrative
$86,350K
(12.99%↑ Y/Y)
Net income
$14,496K
(499.75%↑ Y/Y)
Provision for income taxes
$4,244K
(501.99%↑ Y/Y)
Back
Back
Income Statement
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)
source: myfinsight.com